EchoSolv AS vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoSolv AS

by Echo IQ

DeepRhythmAI

by Medicalgorithmics

AI Verdict

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis by analyzing echocardiogram measurements, providing clinical decision support for valvular heart disease. In contrast, DeepRhythmAI focuses on revolutionizing cardiac arrhythmia detection and classification through AI-powered analysis of ECG data. While both are FDA-cleared, cloud-based cardiology AI tools, they address distinct cardiac conditions and utilize different diagnostic data types.

Choose EchoSolv AS if…

Choose EchoSolv AS if your primary need is to accurately and efficiently identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This tool is ideal for clinical settings looking to streamline the review process, prioritize studies for closer examination, and gain consistent, measurement-based AI insights into sAS probability without requiring EMR integration.

View EchoSolv AS →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your focus is on enhancing the accuracy and speed of cardiac arrhythmia detection and classification from diverse ECG data sources. This platform is best suited for healthcare providers seeking a device-agnostic, AI-powered solution to significantly reduce missed diagnoses and improve the efficiency of ECG reporting across a wide range of arrhythmias.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoSolv AS	DeepRhythmAI
Pricing	Unknown	Contact vendor for pricing information
Deployment	Cloud-based	Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

EchoSolv AS emphasizes ease of integration by stating it requires no EMR integration and directly integrates with PACS, suggesting a simpler setup process. Its 'measurement-based AI' also implies a straightforward data input method, contributing to a less disruptive workflow adoption.

Clinical Value

DeepRhythmAI

DeepRhythmAI provides compelling quantitative evidence of its clinical impact, claiming to reduce missed diagnoses by 14x to 114x. Its training on over 250 billion annotated heartbeats further underscores a robust and highly validated AI model, leading to superior accuracy and efficiency in arrhythmia detection.

Pricing & Value

Tie

Both EchoSolv AS and DeepRhythmAI operate on enterprise or subscription-based models without publicly disclosed pricing details. While EchoSolv AS mentions a 'fee-per-use basis' and DeepRhythmAI highlights large contract values, neither offers transparent pricing for direct comparison, making it impossible to determine a winner for this dimension.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI demonstrates strong enterprise readiness with its longer operational history since 2005, a global customer base, and explicit API availability for seamless integration. It targets a wide range of healthcare providers from solo practitioners to large health systems, further highlighting its scalability and adaptability for diverse enterprise environments.

Innovation

DeepRhythmAI

DeepRhythmAI showcases a higher degree of innovation by explicitly utilizing advanced AI architectures like CNN and Transformer models. Furthermore, its training on an exceptionally vast dataset of over 250 billion annotated heartbeats demonstrates a significant investment in cutting-edge AI development and robust model performance.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding the support channels, documentation quality, or service level agreements for either EchoSolv AS or DeepRhythmAI. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoSolv AS	DeepRhythmAI
Product Name	EchoSolv AS	DeepRhythmAI
Company	Echo IQ	Medicalgorithmics S.A.
Primary Clinical Focus	Identifies patients at risk for severe aortic stenosis	Cardiac arrhythmia detection and classification from ECG data
Key AI Application/Method	AI-powered clinical decision support for severe aortic stenosis probability; measurement-based AI (analyzes numerical measurements, not images)	AI-powered arrhythmia detection and classification; utilizes CNN and Transformer models; trained on 250 billion+ annotated heartbeats
Integration Capabilities	Designed to fit existing workflows (no EMR integration required, integrates with PACS)	Device-agnostic and integrates with various ECG devices
Speed/Efficiency Claims	Ultra-fast risk detection (under 3 seconds); Faster clinical review	Faster ECG reporting and analysis; Streamlines clinical workflows (up to 65% efficiency increase)

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and DeepRhythmAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions do these AI tools help diagnose or manage?

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis (sAS) by analyzing echocardiograms. DeepRhythmAI, on the other hand, focuses on revolutionizing cardiac arrhythmia detection and classification from ECG data.

What type of patient data is required for each tool's analysis?

EchoSolv AS analyzes numerical measurements from echocardiograms and is designed not to use LVOT measurements. DeepRhythmAI utilizes ECG data for its AI-powered arrhythmia detection and classification.

How do these tools integrate into existing clinical workflows?

EchoSolv AS is designed to fit existing workflows by integrating with PACS and does not require EMR integration. DeepRhythmAI is device-agnostic, integrating with various ECG devices to streamline clinical workflows and reporting.

What are the key performance benefits or efficiency gains claimed by each tool?

EchoSolv AS claims high accuracy and efficiency in identifying severe AS probability with ultra-fast risk detection under 3 seconds. DeepRhythmAI claims superior accuracy and efficiency for arrhythmia detection, reducing missed diagnoses by 14x to 114x and increasing workflow efficiency by up to 65%.

What is the underlying AI approach or training data for each tool?

EchoSolv AS uses measurement-based AI that analyzes numerical measurements from echocardiograms. DeepRhythmAI utilizes CNN and Transformer models, trained on over 250 billion annotated heartbeats for arrhythmia detection.